Health By Andrew Joseph U.S. reports 180 cases of unexplained hepatitis in children, as researchers investigate potential causes
Biotech By Jonathan Wosen ‘No real clear path’: Insurance coverage for cutting-edge diagnostics remains a major challenge for personalized medicine
Pharmalot By Ed Silverman Pharmalittle: Cancer coalition aims to boost access to meds in poor countries; Moderna’s vaccine patent defense poses shield for others
First Opinion By Michael L. Millenson and J. Matthew Austin To improve safety, hospitals should make ‘radical transparency’ real — and accessible
First Opinion By Steven C. Schlozman Hopelessness around youth mental health is creating a ‘nihilistic contagion’
Health By Olivia Goldhill Vague ‘medical emergency’ exceptions in abortion laws leave pregnant people in danger, doctors say
The Watchdogs By Ivan Oransky and Adam Marcus Many clinical trials’ findings never get published. Here’s why that’s bad
The Watchdogs By Ivan Oransky and Adam Marcus NEJM editorial doubles down on resistance to data sharing
Biotech By Meghana Keshavan Elizabeth Warren demands open access to data from patient trials of drugs
The Watchdogs By Ivan Oransky and Adam Marcus With a new owner, the hated ‘journal impact factor’ is overdue for a change
The Watchdogs By Ivan Oransky and Adam Marcus A new e-journal could be a ‘game-changer.’ But will scientists come?
The Watchdogs By Ivan Oransky and Adam Marcus For science to improve, let’s put the right prizes on offer
The Watchdogs By Ivan Oransky and Adam Marcus Criticism of ‘research parasites’ moves NEJM in the wrong direction
The Watchdogs By Ivan Oransky and Adam Marcus Fake study on moms’ kisses risked sowing confusion just for a laugh